IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q2 2020 Holdings

Filed 2020-08-07 | 5 holdings | $154.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$74.4K3,766,66648.2%
Cara Therapeutics Inc(CARAEUR)COM140755109$47.9K2,799,05831.0%
Mersana Therapeutics IncCOM59045L106$18.6K796,45812.1%
Livexlive Media IncCOM NEW53839L208$13.5K3,724,1388.7%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$62159,6010.0%